Sangamo Therapeutics (SGMOQ) Return on Assets (2011 - 2025)
Sangamo Therapeutics (SGMOQ) posted quarterly Return on Assets of 0.02% for Q4 2025, down 1.0% year-over-year from 0.02% in Q4 2024, and down 41.64% quarter-over-quarter from 0.01% in Q3 2025.
Sangamo Therapeutics (SGMOQ) Return on Assets (2011 - 2025) Analysis & Trends
Sangamo Therapeutics' Return on Assets history runs 15 years deep, the most recent figure standing at 0.02% for Q4 2025.
- In Q4 2025, Return on Assets fell 1.0% year-over-year to 0.02%; the TTM figure through Dec 2025 stood at 0.02% (down 1.0% YoY), while the FY2025 annual figure was 0.02%, down 1.0% from the prior year.
- Return on Assets for Q4 2025 stood at 0.02%, down from 0.01% in the prior quarter.
- The five-year high for Return on Assets was 0.0% in Q1 2021, with the low at 0.02% in Q2 2024.
- The 5-year median for Return on Assets is 0.01% (2023), against an average of 0.01%.
- The sharpest annual moves came in 2024 and 2025: Return on Assets declined 2 bps in 2024, then rose 2 bps in 2025.
- Sangamo Therapeutics' Return on Assets stood at 0.0% in 2021, then sank by 39 bps to 0.0% in 2022, then tumbled by 303 bps to 0.01% in 2023, then surged by 31 bps to 0.01% in 2024, then tumbled by 80 bps to 0.02% in 2025.
- Business Quant data shows SGMOQ's Return on Assets at 0.02% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |